TargetMol

CID-797718

Product Code:
 
TAR-T1858
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1858-1mg1mg£193.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-2mg2mg£252.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-5mg5mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-1mL1 mL * 10 mM (in DMSO)£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-10mg10mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-25mg25mg£707.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-50mg50mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1858-100mg100mg£1,291.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CID797718 is a protein kinase D1 (PKD1) inhibitor.
CAS:
370586-05-3
Formula:
C12H11NO3
Molecular Weight:
217.224
Pathway:
Cell Cycle/Checkpoint; Metabolism
Purity:
0.9925
SMILES:
Oc1ccc2oc(=O)c3NCCCc3c2c1
Target:
Serine/threonin kinase

References

1. LaValle, C., Bravo-Altamirano, K., Giridhar, K., Chen, J., Sharlow, E., & Lazo, J. et al. (2010). Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.?BMC Chemical Biology,?10(1), 5. doi: 10.1186/1472-6769-10-5